Literature DB >> 21491540

Isolation, proliferation, cytogenetic, and molecular characterization and in vitro differentiation potency of canine stem cells from foetal adnexa: a comparative study of amniotic fluid, amnion, and umbilical cord matrix.

M Filioli Uranio1, L Valentini, A Lange-Consiglio, M Caira, A C Guaricci, A L'Abbate, C R Catacchio, M Ventura, F Cremonesi, M E Dell'Aquila.   

Abstract

The possibility to isolate canine mesenchymal stem cells (MSCs) from foetal adnexa is interesting since several canine genetic disorders are reported to resemble similar dysfunctions in humans. In this study, we successfully isolated, cytogenetically and molecularly characterized, and followed the differentiation potency of canine MSCs from foetal adnexa, such as amniotic fluid (AF), amniotic membrane (AM), and umbilical cord matrix (UCM). In the three types of cell lines, the morphology of proliferating cells typically appeared fibroblast-like, and the population doubling time (DT) significantly increased with passage number. For AF- and AM-MSCs, cell viability did not change with passages. In UCM-MSCs, cell viability remained at approximately constant levels up to P6 and significantly decreased from P7 (P < 0.05). Amnion and UCM-MSCs expressed embryonic and MSC markers, such as Oct-4 CD44, CD184, and CD29, whereas AF-MSCs expressed Oct-4, CD44. Expression of the hematopoietic markers CD34 and CD45 was not found. Dog leucocyte antigens (DLA-DRA1 and DLA-79) were expressed only in AF-MSCs at P1. Isolated cells of the three cell lines at P3 showed multipotent capacity, and differentiated in vitro into neurocyte, adipocyte, osteocyte, and chondrocyte, as demonstrated by specific stains and expression of molecular markers. Cells at P4 showed normal chromosomal number, structure, and telomerase activity. These results demonstrate that, in dog, MSCs can be successfully isolated from foetal adnexa and grown in vitro. Their proven stemness and chromosomal stability indicated that MSCs could be used as a model to study stem cell biology and have an application in therapeutic programs.
Copyright © 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21491540     DOI: 10.1002/mrd.21311

Source DB:  PubMed          Journal:  Mol Reprod Dev        ISSN: 1040-452X            Impact factor:   2.609


  30 in total

1.  Could fetal fluid and membranes be an alternative source for mesenchymal stem cells (MSCs) in the feline species? A preliminary study.

Authors:  Eleonora Iacono; Marco Cunto; Daniele Zambelli; Francesca Ricci; Pier Luigi Tazzari; Barbara Merlo
Journal:  Vet Res Commun       Date:  2012-02-12       Impact factor: 2.459

2.  Human mesenchymal stem cells derived from limb bud can differentiate into all three embryonic germ layers lineages.

Authors:  Fei Jiao; Juan Wang; Zhao-Lun Dong; Min-Juan Wu; Ting-Bao Zhao; Dan-Dan Li; Xin Wang
Journal:  Cell Reprogram       Date:  2012-07-09       Impact factor: 1.987

Review 3.  Age-associated changes in regenerative capabilities of mesenchymal stem cell: impact on chronic wounds repair.

Authors:  Bin Yao; Sha Huang; Dongyun Gao; Jiangfan Xie; Nanbo Liu; Xiaobing Fu
Journal:  Int Wound J       Date:  2015-10-01       Impact factor: 3.315

Review 4.  Amniotic fluid cells: current progress and emerging challenges in renal regeneration.

Authors:  Stefano Da Sacco; Laura Perin; Sargis Sedrakyan
Journal:  Pediatr Nephrol       Date:  2017-06-15       Impact factor: 3.714

5.  Comparison of cell proliferation and epigenetic modification of gene expression patterns in canine foetal fibroblasts and adipose tissue-derived mesenchymal stem cells.

Authors:  H J Oh; E J Park; S Y Lee; J W Soh; I S Kong; S W Choi; J C Ra; S K Kang; B C Lee
Journal:  Cell Prolif       Date:  2012-10       Impact factor: 6.831

Review 6.  Advances in translational orthopaedic research with species-specific multipotent mesenchymal stromal cells derived from the umbilical cord.

Authors:  Melina Ramallo; Irene Carreras-Sánchez; Alba López-Fernández; Roberto Vélez; Màrius Aguirre; Sara Feldman; Joaquim Vives
Journal:  Histol Histopathol       Date:  2020-09-11       Impact factor: 2.303

7.  The bone regenerative capacity of canine mesenchymal stem cells is regulated by site-specific multilineage differentiation.

Authors:  Juan Bugueño; Weihua Li; Pinky Salat; Ling Qin; Sunday O Akintoye
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol       Date:  2016-09-28

Review 8.  Amniotic fluid-derived stem cells for cardiovascular tissue engineering applications.

Authors:  Jennifer Petsche Connell; Gulden Camci-Unal; Ali Khademhosseini; Jeffrey G Jacot
Journal:  Tissue Eng Part B Rev       Date:  2013-03-14       Impact factor: 6.389

9.  Isolation and characterization of Wharton's jelly-derived multipotent mesenchymal stromal cells obtained from bovine umbilical cord and maintained in a defined serum-free three-dimensional system.

Authors:  Tereza C Cardoso; Heitor F Ferrari; Andrea F Garcia; Juliana B Novais; Camila Silva-Frade; Marina C Ferrarezi; Alexandre L Andrade; Roberto Gameiro
Journal:  BMC Biotechnol       Date:  2012-05-04       Impact factor: 2.563

10.  Susceptibility of neuron-like cells derived from bovine Wharton's jelly to bovine herpesvirus type 5 infections.

Authors:  Tereza C Cardoso; Juliana B Novais; Talita F Antello; Camila Silva-Frade; Marina C Ferrarezi; Heitor F Ferrari; Roberto Gameiro; Eduardo F Flores
Journal:  BMC Vet Res       Date:  2012-12-10       Impact factor: 2.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.